The latest immunotherapy news and developments
A study by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests that injecting engineered dendritic…
Researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine…
A second-generation melanoma vaccine being developed at UVA Cancer Center, USA, improves long-term survival for…
Researchers have developed a genetic test that can identify how patients with triple negative early-stage…
Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer…
Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed…
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…
The Oncology Podcast, part of The Oncology Network, is proud to present Episode 3 in the…
Making a personalised T cell therapy for cancer patients currently takes at least six months;…
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed),…